Stephen C. Glover - 12 Jan 2026 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Role
Director
Signature
/s/ Spencer Brown, as Attorney-in-Fact
Issuer symbol
PDSB
Transactions as of
12 Jan 2026
Net transactions value
$0
Form type
4
Filing time
03 Mar 2026, 18:47:21 UTC
Previous filing
15 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Glover Stephen C. Director C/O PDS BIOTECHNOLOGY CORPORATION, 303A COLLEGE ROAD EAST, PRINCETON /s/ Spencer Brown, as Attorney-in-Fact 03 Mar 2026 0001304406

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PDSB Employee Stock Option (Right to Buy) Award $0 +54,876 $0.000000 54,876 12 Jan 2026 Common Stock 54,876 $0.9800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.